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performance of mNGS of CSF for the diagnosis of central nervous system (CNS) 1 2 9 infections compared to conventional microbiological methodologies. This study was a multicentre prospective cohort assessment of the mNGS of CSF for 1 3 4 the diagnosis of suspected infectious encephalitis or meningitis. The participating 1 3 5 sites were 20 hospitals located in 10 provinces/municipalities in China. Each hospital 1 3 6 is a member of the Beijing Encephalitis Group. Adult patients were eligible for 1 3 7 inclusion in the study if they presented with clinical manifestations consistent with 1 3 8 either encephalitis or meningitis (Table 1) and if standard diagnostic examinations 1 3 9
( Supplementary Table 1 ) failed to identify an etiological cause within 3 days. 1 4 0
Exclusion criteria are shown in Table 1 . were consistent with that pathogen. All patients were treated based on the results of 1 4 9 9 sequences. The remaining reads were aligned to the database of annotation, which 1 7 3 includes the NCBI microbial genome database (ftp://ftp.ncbi.nlm.nih.gov/genomes/) 1 7 4 to detect pathogens. The sequencing data was analysed in terms of the numbers of raw 1 7 5 reads, non-human reads, and reads aligned to the microbial genome database as well 1 7 6 as species-specific reads (genus-specific reads for Mycobacterium tuberculosis and 1 7 7
Brucella), reads per million (RPM), and genome coverage (%). The results of mNGS 1 7 8
were available in less than 48 hrs. To reduce the influence of potential contamination, we used the following criteria for 1 8 2 positive results of CSF mNGS: The performance of the criteria were evaluated at the finally stage of the study, 2 0 6 the original results of mNGS and/or clinical manifestations were used to guide the 2 0 7 further testing of conventional microbiological studies. data are expressed as medians with interquartile ranges (IQRs) or as means ± standard 2 1 3 deviation. 3.1 Characteristics of the study participants 2 1 7 287 patients were screened for inclusion in this study ( Fig. 1 ). 11 patients were 2 1 8 initially thought to have CNS infections and mNGS was performed. However, these 2 1 9 cases were ultimately excluded following the final diagnosis of a non-infectious 2 2 0 disease. Of these 11 excluded patients, 10 had negative mNGS results, and 1 patient 2 2 1 receiving immunosuppressive therapy was positive for BK polyomavirus. The final 2 2 2 cohort included 276 patients in the study. 176 (63.8%) were male and the median age 2 2 3 was 42 years (IQR: 26-54 years). The median time from disease-onset to CSF 2 2 4 sampling was 10 days (IQR: 5-25 days). The median white blood cell count in CSF 2 2 5 was 80/mm 3 (IQR: 19-220/mm 3 ). The median CSF monocyte cell count was 36/mm 3 2 2 6 (IQR: 10-127/mm 3 ). During a follow-up period of 30 days, nine patients died. 276 CSF samples were tested by mNGS and conventional microbiological studies. 122 2 3 0 samples were positive by mNGS (110 true positive, 12 false positive), 126 were 2 3 1 positive by conventional microbiological tests, and 114 total positive results were 2 3 2 considered "Etiologic Pathogens" ( Table 2 ). All mNGS results were obtained in less 2 3 3 than 48 hours and 101 CSF samples were positive by mNGS before any conventional 2 3 4 microbiological tests were positive. Of the patients first diagnosed by mNGS, 16.3% of infections were caused by 2 3 6 bacterial, 15.2% by viruses, 2.9% by fungi, and 2.2% by parasites ( Fig. 2A) . In total, NGS detected 11 bacterial species, of which M. tuberculosis (14 cases, 1 2 13.9%) and L. monocytogenes (7.9%) were the most common ( Fig. 2B) , 7 viral 2 3 9 species (BK polyomavirus was not the etiologic pathogen), of which VZV (16.8%) 2 4 0 and HSV1 (11.9%) were the most common, 2 fungal species, both of which were 2 4 1 Cryptococcus (7.9%), and 2 parasitic species, of which T. solium (5.0%) was the most 2 4 2 common. Nine co-infections with Epstein-Barr virus (EBV) (three with HSV1, two 2 4 3
with Brucella, one with Cryptococcus, one with S. haemolyticus, one with P. with BK polyomavirus (with HSV1) were detected. The EBV and BK polyomavirus 2 4 7 did not appear to be consistent with the clinical manifestations in these two instances 2 4 8 of co-infections. conventional microbiological methods might fail to detect the Mycobacterium 2 7 5 tuberculosis. Of note, there were three false negative cases of Cryptococcus infection. To the best of our knowledge, the present study is the first to assess the performance 2 7 9 of mNGS for pathogen identification in a large prospective cohort of patients with 2 8 0 suspected CNS infections. Specifically, our study compared results of mNGS of CSF 2 8 1 to conventional microbiological studies and proposed new criteria for validating a 1 4 mNGS result as positive for therapeutic decision-making. Our results suggest that 2 8 3 NGS can provide a quicker and more accurate etiologic pathogen identification than 2 8 4 conventional microbiological methods. However, patients in the present study were 2 8 5 only eligible to be assessed by mNGS if conventional microbiological studies, e.g. 2 8 6 routine bacterial stains and cultures, India ink preparation, targeted PCR tests, 2 8 7 serological tests, failed to identify an etiologic cause within 3 days. Thus, the 2 8 8 application of CSF mNGS in the clinical setting of this study could be regarded as a 2 8 9 quasi-first line method for diagnosing CNS infectious diseases. 2 9 0 mNGS is a high-throughput sequencing technique without the requirement of 2 9 1 prior information, allowing detection of unsuspected or novel organisms. Importantly, 2 9 2 mNGS can detect unsuspected pathogens that clinicians may fail to consider because 2 9 3 of atypical clinical manifestations. Many cases of neurological infections have been 2 9 4 unexpectedly diagnosed by mNGS of CSF 11, 22, 29, 30 similar to the present study for the 2 9 5 cases of L. monocytogenes, Brucella and T. solium [12] [13] [14] . In addition, as demonstrated 2 9 6 in previous studies 10, 20, 21 and in the present study for the case of encephalitis caused 2 9 7
by Suid herpesvirus 1 31 , mNGS of CSF has the ability to identify novel aetiologies of 2 9 8 CNS infections. Furthermore, NGS can detect unexpected co-infections that may 2 9 9 guide appropriate targeted treatment. For example, we detected co-infections of CMV 3 0 0 and Cryptococcus. In routine clinical practice, if conventional microbiological 3 0 1 methods detect Cryptococcus, then no further tests for other microorganisms other 3 0 2 than HIV are usually performed. Finally, mNGS of CSF may be an appropriate tool 3 0 3 for ruling out a broad spectrum of potential CNS infectious diseases prior to 3 0 1 5 concluding a final diagnosis of autoimmune diseases, such as autoantibody-negative 3 0 5 autoimmune encephalitis. 3 0 6
Contamination of samples during specimen collection and/or processing is a 3 0 7 major challenge when interpreting mNGS results. To reduce the potential influence of 3 0 8 contamination, we defined strict criteria for positive mNGS results. The various types 3 0 9
of contamination observed in the present study could be divided into two groups: (1) 3 1 0 microorganisms commonly associated with background contamination that did not 3 1 1 meet the criteria for a positive result ( Supplementary Table 2 ) and (2) are not likely to be false positives.
6
Negative mNGS results do not necessarily exclude an infectious cause for the 3 2 7 patient's illness. In the present study, false negative mNGS results occurred in 5.8% of 3 2 8 cases and included bacterial, viral, and fungal infections. The prior use of antibiotics 3 2 9
can affect the detection rate of bacteria. Low SSRN values (1 or 2 reads) Our results indicate that mNGS of CSF is a very useful test for the diagnostic 3 3 9 evaluation of patients with suspected CNS infections. mNGS has already become a 3 4 0 first-line laboratory method in the response to emerging infectious diseases and 3 4 1 outbreaks of infectious diseases 41, 42 . Moreover, increasing evidence provides a 3 4 2 rationale for using mNGS as a first-line diagnostic test for chronic and recurring 3 4 3 encephalitis and as a second-line test for acute encephalitis 23 . In the present study, 3 4 4 more than one-third of patients were first diagnosed by mNGS of CSF within 48 hrs, 3 4 5
indicating that this technique can be extremely useful for rapid clinical 3 4 6 decision-making. mNGS of CSF should be considered as a first-line test for acute 3 4 7 1 7 therapy, (2) the clinical manifestations are non-specific and numerous target-specific 3 4 9 tests are simultaneously applied to identify an infectious cause, 3) a broad spectrum of 3 5 0 potential pathogens needs to be ruled out to diagnose a suspected autoimmune 3 5 1 encephalitis, and (4) rare or novel pathogens are suspected for which standard 3 5 2 target-specific tests are not available. There are several limitations regarding the current use of mNGS of CSF in 3 5 4 routine clinical settings. First, mNGS is not available in many hospitals and the cost is 3 5 5 usually much higher than target-specific tests. Second, the detection of DNA of a 3 5 6 certain pathogen does not necessarily prove that it is responsible for the patient's 3 5 7 clinical presentation and features 23, 27 . In the present study, some patients were positive 3 5 8 for EBV but had other more likely aetiologies of their infections. EBV DNA has often 3 5 9 been identified together with other microorganisms in CSF 43 . Finally, mNGS cannot 3 6 0 detect microorganisms that are not included in microbial genome databases. Our study has several limitations. Reverse transcription was not performed to 3 6 2 construct a DNA library and therefore, RNA viruses could not be detected by mNGS. 3 6 3
Next-generation RNA sequencing should be performed in future prospective studies. 3 6 4
The number of CNS infections caused by each pathogen were not sufficient to assess 3 6 5 the sensitivity and specificity of mNGS for individual pathogens. Finally, we may 3 6 6 have underestimated the sensitivity of mNGS of CSF for diagnosing CNS infections 3 6 7 by employing strict criteria for a positive mNGS result and using conventional 3 6 8 microbiological methods as the gold standard. ≥ 5/cubic mm Abnormality of brain parenchyma on neuroimaging suggestive of encephalitis that is either new from prior studies or appears acute in onset Abnormality on EEG that is consistent with encephalitis and not attributable to another cause. Exclusion criteria for encephalitis ≤ 28 days of age Non-infectious encephalitis, such as autoimmune disorders, paraneoplastic syndromes, NMOSD, neuropsychiatric involvement of rheumatic diseases HIV or syphilis infection History of recent (within 4 weeks before the onset of disease) vaccination Meningitis without clinical brain parenchyma involvement Absolute contraindications for lumbar puncture; Traumatic LP with obvious blood-contaminated CSF Pregnancy Refusal to sign the informed consent
Case definitions for meningitis
Patients presenting to medical attention with at least two of the four symptoms of headache, fever (documented fever ≥ 38 within the 72 hrs before or after presentation), neck stiffness, decreased level of consciousness (defined by a Glasgow Coma Scale score below 14) CSF white blood cell count ≥ 5/cubic mm Exclusion criteria for meningitis ≤ 28 days of age HIV or syphilis infection Meningeal malignancy confirmed by CSF cytology Traumatic LP with obvious blood-contaminated CSF Pregnancy Refusal to sign the informed consent 0 with NGS of CSF, 16.3% were diagnosed with bacterial infections, 15.2% with viral 5 7 9 infections, 2.9% with fungal infections, and 2.2% with parasitic infections. (B) NGS 5 8 0 detected 11 bacterial species, the most common of which were M. tuberculosis 5 8 1 (13.9%) and L. monocytogenes (7.9%), 7 viral species, the most common of which 5 8 2 were VZV (16.8%) and HSV1 (11.9%), 2 fungal species, both of which were 5 8 3 Cryptococcus (7.9%) species, and 2 parasitic species, the most common of which was 5 8 4 T. solium (5.0%). 5 8 5
